Refine by
Vor Preclinical Study Equipment & Supplies
1 equipment items found
by:Vor Biopharma based inCambridge, MASSACHUSETTS (USA)
Once the VOR33 cells have engrafted, we believe that patients can be treated with anti-CD33 therapies, such as Mylotarg or VCAR33, with limited on-target toxicity, leading to durable anti-tumor activity and potential cures. In preclinical studies, we have observed that the removal of CD33 provided robust protection of these healthy donor HSCs from the cytotoxic ...